🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

So excited to see this in print! Congrats Mendel Goldfinger and our excellent heme malignancies team!

Easy-to-digest Research Briefing on our new article in Nature Cancer: Co-targeting metabolism and epigenetics to treat #cancer patients with #MDS and #AML. Amit Verma Marina Konopleva Albert Einstein College of Medicine - Official EinsteinSCI nature.com/articles/s4301…

Congrats to all the winners of the Einstein Science Strong poster competition including our own Shira Glushakow-Smith Shira G-S, PhD!

Such amazing news for Einstein today! Congrats to Teresa Bowman Bowmaniacs!

🎉Excited to present our latest work out today nature 1.What gives a leukemia its phenotype – the oncogenic driver or the differentiation stage of the cell-of-origin? 2.Why do RAS mutations always happen late in AML? 3.Who will relapse after VEN? nature.com/articles/s4158…

We had fun closing out the season on our lab apple picking trip today!

Thrilled to learn from Dr. Anna E. Beaudin Anna E. Beaudin UofUHeme about the lasting impact of early-stage blood cells and prenatal nutrients on hematopoiesis and human disease. Great discussions with EinsteinSCI faculty over dinner! Albert Einstein College of Medicine - Official

Congratulations Teresa! Well deserved!

Check out our new review by the amazing Alexandra Schurer and Shira Glushakow-Smith Shira G-S, PhD on chromatin modifiers in AML!@EinsteinCellBio EinsteinSCI Einstein MSTP EinsteinPhD

I am so happy to meet friends at ASH and enjoy the amazing talks! This is a special year. Join us at the ASH Plenary Session. My very talented postdoc, Sen Zhang, will present her work on the role of PF4 in Hematopoietic Stem Cell Aging 👏👏👏 #ASH2024 ASH University of Illinois College of Medicine

What plenary? Best of #ASH2024 Stephen D. Nimer, MD Respect 🙌 #miaminights Sylvester Comprehensive Cancer Center

Check out the talk by my amazing grad student, Ian Ghezzi this morning at #ASH2024. Using a novel mouse model, he’s been able to identify a rare population of dormant JAK2-mutant HSCs that drive disease propagation and therapy resistance in MPNs.

Excited to share our latest contribution describing the role of inflammation in regulating defective hematopoiesis in RUNX1-familial platelet disorder & identifying CD74/mTORC/JAK axis as one of the drivers of inflammation Science Translational Medicine OHSU Knight Cancer Institute OHSU News science.org/doi/10.1126/sc…

🚨Apparently all NIH Study Sections have been suspended indefinitely. For those who don’t know, this means there won’t be any review of grants submitted to NIH Depending on how long this goes on for, this could lead to an interruption in billions in research funding.

Really looking forward to this meeting!

🔥 Excited for our Phase 1 study Ven + 7+3 for Newly Diagnosed AML demonstrating 85% CR (86% MRD-neg) Blood Journal @ MontefioreNYC Albert Einstein College of Medicine - Official Montefiore Health System Eric J. Feldman Mendel Goldfinger Marina Konopleva Amit Verma Aditi Shastri, MD Kira Gritsman #leusm doi.org/10.1182/blood.…

About a month after Donald Trump took office as the 47th US president, almost all grant-review meetings remain suspended at the US National Institutes of Health (NIH), preventing the world’s largest public funder of biomedical research from spending much of its US$47 billion

So excited that our collaboration with David Shechter on a targetable PTM - glutamylation - on NPM1c in AML, led by Alex Schurer and Humaira is now on BiorXiv!

Congratulations to Uli Steidl on this very well deserved honor!

Our trainees had a truly enriching experience at #KUHRTN2025 at Emory School of Medicine, Atlanta! They gained insights into career development, received valuable advice, and enjoyed connecting with field leaders and peers (@KUHR_Trainees) from across the country. bit.ly/3H529IZ